Kinetics and thermodynamics of acoustic release of doxorubicin from non-stabilized polymeric micelles by Husseini, Ghaleb

Get full text

Mental Stress Assessment in the Workplace: A Review by Masri, Ghinwa

Get full text

Distribution of Doxorubicin in Rats Undergoing Ultrasonic Drug Delivery by Staples, Bryant J.

Get full text

Power System Transient Stability Assessment Based on Machine Learning Algorithms and Grid Topology by Senyuk, Mihail

Get full text

Functional fatigue of Ni50.3Ti25Hf24.7 - Heterogeneities and evolution of local transformation strains by Abuzaid, Wael

Get full text

Bulk passivation of perovskite films utilizing halide anion ionic liquids by Alashkar, Adnan

Get full text

TCAD Simulation and Analysis of Selective Buried Oxide MOSFET Dynamic Power by Mahmoud, Rana

Get full text

Evaluation of Workability and Structuration Rate of Locally Developed 3D Printing Concrete Using Conventional Methods by Ahmed, Sara

Get full text

Elastic Buckling Behavior of Functionally Graded Material Thin Skew Plates with Circular Openings by Alashkar, Adnan

Get full text

In-Vitro Degradation of Hollow Silica Reinforced Magnesium Syntactic Foams in Different Simulated Body Fluids for Biomedical Applications by Manakari, Vyasaraj

Get full text

Characterization of Contusive Spinal Cord Injury by Monitoring Motor-Evoked Potential by ALL, Angelo H.

Get full text

Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 co... by Alize J, Ferrari

“…Globally between 2010 and 2021, the age-standardised DALY rates for HIV/AIDS decreased by 47·8% (43·3–51·7) and for diarrhoeal diseases decreased by 47·0% (39·9–52·9). …”
Get full text
Get full text
Get full text

The Development of Metal-Free Porous Organic Polymers for Sustainable Carbon Dioxide Photoreduction by Bariki, Ranjit

Get full text

Environmental Footprint and Economics of a Full-Scale 3D-Printed House by Abdalla, Hadeer

Get full text

دور مكاتب الإصلاح والوساطة والتوفيق الأسري في الأردن في الحد من النزاعات الأسرية من وجهة نظر العاملين بها... by Al-Oqaili , Amneh Irshied

Get full text

Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 by Joan B Soriano (6458528)

“…Premature mortality from chronic respiratory diseases seems to be highest in regions with less-resourced health systems on a per-capita basis. Funding Bill & Melinda Gates Foundation.…”

Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2... by Michael, Brauer

“…Estimates reported represent the mean value across 500 draws from the estimate's distribution, with 95% uncertainty intervals (UIs) calculated as the 2·5th and 97·5th percentile values across the draws. …”
Get full text
Get full text
Get full text

Global, regional, and national burden of HIV/AIDS, 1990–2021, and forecasts to 2050, for 204 countries and territories: the Global Burden of Disease Study 2021 by Austin, Carter

“…HIV-related deaths decreased by 39·7% (33·7–44·5), from 1·19 million (1·07–1·37) in 2010 to 718 000 (669 000–785 000) in 2021. …”
Get full text
Get full text
Get full text

Global, regional, and national mortality among young people aged 10–24 years, 1950–2019: a systematic analysis for the Global Burden of Disease Study 2019 by Joseph L Ward (9715619)

“…Since 1950, deaths in this age group decreased by 30·0% in females and 15·3% in males, and sex-based differences in mortality rate have widened in most regions of the world. …”

The cost-benefit associated with the maturity of the Antimicrobial Stewardship Program versus prematurity in Heart Hospital of Hamad Medical Corporation in Qatar by Dina Abushanab (10696501)

“…With M-ASP, cost of hospital tests use ‘decreased’ by QAR 1,149 per 100-patient beds per year, cost of ASP personnel ‘decreased’ by QAR 125 per 100-patient beds with the M-ASP, cost of drug use ‘increased’ by QAR 176,848 per 100-patient beds, cost of resistance and hospitalization ‘increased’ by QAR 216,279 per 100-patient beds per year. …”